Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections
Status: Recruiting
Location: See location...
Intervention Type: Biological, Other
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:
• Female subjects aged ≥18
• History of recurrent UTI: at least two episodes of UTI over the past 6 months or at least three episodes over the past year, most recent episode within the past three months
• Written informed consent
Locations
Other Locations
Finland
Meilahti Vaccine Research Center, Helsinki University Central Hospital
RECRUITING
Helsinki
Contact Information
Primary
Sari Pakkanen, PhD
vti-tutkimus@hus.fi
+358 50 4482769
Time Frame
Start Date: 2023-08-01
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 100
Treatments
Experimental: Feacal microbial transplantation (FMT)
Placebo_comparator: Placebo transplantation (PT), transplantation with coloured 0,9% NaCl-solution
Related Therapeutic Areas
Sponsors
Collaborators: University of Helsinki
Leads: Helsinki University Central Hospital